The competition for highly skilled talent, life sciences companies have much to consider for the remainder of 2022.
The need for life science companies to grow and thrive means they need to address the continuous challenge of hiring within a highly competitive landscape – however, this is where we feel innovation and opportunity lie.
Across the life science, biopharma, and MedTech sectors, the industry is often vying for the same talent pool, addressing resource and talent pipelines in the first step for companies to grow and crucially remain competitive and allow them to innovate and grow.
Market changes and, of course, a global pandemic catapulted the need for the life science industry to adapt quickly and invest in digital technologies to improve every aspect of their supply chains.
With that – comes a need for highly attuned talent to deliver on new and exciting innovations within the industry.
With the lightning speed of new technologies fueling the growth and requirement for a digitally competent life science workforce, employers must assess long-term hiring plans alongside short-term and critical needs.
The US life sciences industry has transformed dramatically in such a short time – pushing many companies to become more reactive and take stock of what they can offer employees to be as attractive as possible to new talent.
From assessing the workplace culture to compensation and progression routes, auditing and improving employer brand is now top of the agenda for companies seeking out the next generation of life science talent.
Accessing emerging talent from the nation’s colleges and universities is now an increasing focus for many employers, who have embraced a partnership model to engage the new generation of life science workers.
Growing a pipeline of talent that will grow sufficiently in line with the industry’s expansion and fuel the continued development of the life sciences industry is of primary importance to enable growth, and drive forward the innovations that will shape the future of life sciences.